Further Evidence
Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways.
Bickert, T, et al. - Int Arch Allergy Immunol. 2009;149(3):219-230this abstract at pubmed.com
Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study.
Bär, F., et al. - Neurogastroenterol Motil. 2009; 21(5):559-566this abstract at pubmed.com
Probiotic bacteria Escherichia coli strain Nissle 1917 attenuates acute gastric lesions induced by stress.
Konturek, PC, et al. - J Physiol Pharmacol 2009; 60 (Suppl 6): 41-48.this abstract at pubmed.com
A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice.
Arribas, B., et al. - Brit J Pharmacol 2009; 157(6): 1024-1033.this abstract at pubmed.com
The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic.
Sonnenborn, U., et al. - Microbial Ecology in Health and Disease 2009; 21(3-4): 122-158.no abstract available
Probiotics regulate the expression of COX-2 in intestinal epithelial cells.
Otte, J. M., et al. - Nutr Cancer. 2009;61(1):103-113.this abstract at pubmed.com
The Probiotic Gram-negative E.coli Strain Nissle 1917 Exhibits Antimutagenic Activity Against Different Mutagenic Substances.
Janosch, D., et al. - Int J Med Microbiol 2008; 97: PWP 08no abstract available
The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways.
Guzy, C., et al. - Int Immunol 2008; 20(7): 829-840.this abstract at pubmed.com
Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging.
Brader, P, et al. - Clin Cancer Res 2008; 14: 2295-2302.this abstract at pubmed.com
Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation.
Hernando-Harder, AC - Dig Dis Sci 2008; 53: 443-450.this abstract at pubmed.com
Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice.
Stritzker, J - Int J Med Microbiol 2007; 297(3): 151-162.this abstract at pubmed.com
Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.
Schlee, M. - Infect Immun 2007; 75(5): 2399-2407.no abstract available
Effect of orally administered probiotic E. coli strain Nissle 1917 on intestinal mucosal immune cells of healthy young pigs.
Duncker, S.C., et al. - Vet Immunol Immunopatho 2006; 111(3-4): 239-250.this abstract at pubmed.com
Transcriptional regulation through RfaH contributes to intestinal colonization by Escherichia coli.
Nagy, G., et al. - FEMS Micobiol Lett 2005; 244(1): 173-180.this abstract at pubmed.com
Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis.
Kamada, N., et al. - Inflamm Bowel Dis 2005; 11(5): 455-463.this abstract at pubmed.com
Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model.
Liebregts, T., et al. - Neurogastroenterol Motil 2005; 17(3):410-414.
this abstract at pubmed.com
Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data.
Sun, J., et al. - J Biotechnol 2005; 117(2): 147-161.this abstract at pubmed.com
The effect of intestinal colonization of germ-free pigs with Escherichia coli on calprotectin levels in plasma, intestinal and bronchoalveolar lavages.
Splichal, I., et al. - Immunobiology 2005; 209(9): 681-687.this abstract at pubmed.com
Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via Toll-like receptor 2 signaling.
Sturm, A., et al. - Infect Immun 2005; 73(3): 1452-1465.this abstract at pubmed.com
Intestinal immunity of Escherichia coli Nissle 1917: a safe carrier for therapeutic molecules.
Westendorf, AM, et al. - FEMS Immunol Med Microbiol 2005; 43(3): 373-384.this abstract at pubmed.com
NF-kappaB- and AP-1-mediated induction of human beta Defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.
Wehkamp, J., et al. - Infection and Immunity 2004; 72(10): 5750–5758.this abstract at pubmed.com
Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917.
Grozdanov, L., et al. - J Bacteriol 2004; 186: 5432-5441.this abstract at pubmed.com
The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens.
Altenhöfer, A., et al. - FEMS Immunol Med Microbiol 2004; 40: 223-229.this abstract at pubmed.com
Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of Colitis.
Schultz, M., et al. - Clin Diagn Lab Immunol 2004; 11(2): 372-378.this abstract at pubmed.com
Functional modulation of enterocytes by gram-positive and gram-negative microorganisms.
Otte, J. M. - Am J Physiol Gastrointest Liver Physiol 2004; 286(4): G613-626.this abstract at pubmed.com
Non-pathogenic Escherichia coli inhibits signal transduction pathway in intestinal epithelial cells: A novel mechanism of action.
Maeda, K., et al. - Gastroenterology 2004; 126(4): A-577.no abstract available
Non-pathogenic Escherichia coli prevents acute and chronic colitis in mice.
Kamada, N., et al. - Gastroenterology 2004; 126(4): A-286.no abstract available
Probiotic E. coli Nissle 1917 (EcN) inhibits activation and adhesion of peripheral T-cells to extracellular matrix.
Sturm, A., et al. - Gastroenterology 2004; 126(4): A-578.no abstract available
DNA-Microarray-based comparison of cellular responses in polarized T84 epithelial cells triggered by probiotics: E. coli Nissle 1917 (EcN) and Lactobacillus acidophilus PZ1041.
Cichon, C., et al. - Gastroenterology 2004; 126(4): A-578-579.no abstract available
The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN.
Patzer, S. I. - Microbiology 2003; 149: 2557-2570.this abstract at pubmed.com
Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease.
Boudeau, J., et al. - Aliment Pharmacol Ther 2003; 18: 45-56.this abstract at pubmed.com
Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples.
Blum-Oehler, G., et al. - Res Microbiol 2003; 154: 59-66.this abstract at pubmed.com
A dual function of probiotic E. coli Nissle 1917 (EcN): Inhibition of cell cycle progression for peripheral T-Cells and proapoptotic for mucosal T-Cells.
Sturm, A., et al. - Gastroenterology 2003; 124 (4)Suppl 1: A-155.no abstract available
A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917.
Grozdanov, L., et al. - J Bacteriol 2002; 184(21): 5912-5925.
this abstract at pubmed.com
Probiotics in Gastroenterology.
Fric, P. - Z Gastroenterol 2002; 40(3): 197-201.this abstract at pubmed.com
Gram negative bacteria trigger human intestinal mast cells for histamine and cytokine production.
Sellge, G., et al. - Gastroenterology 2002; 122(Suppl. 4): A-400.no abstract available
The role of the gut flora in inflammatory bowel diseases.
Schulze, J., Sonnenborn, U. - In: Shimoyama T, Axon A, Lee A, Podolsky DK, O'Morain C, editors. Helicobacter meets inflammatory bowel disease.
Tokyo: Medical Tribune Inc.; 2002. p. 393-417.no abstract available
Type 1 fimbriation and phase switching in a natural Escherichia coli fimB null strain, Nissle 1917.
Stentjeberg-Olesen, B., et al. - J Bacteriol 1999; 181(24): 7470-7478.this abstract at pubmed.com
Association of germ-free piglets with two non-pathogenic E. coli strains: Nissle 1917 stimulates the immune system more than 086 strain.
Trebichavsky, I., et al. - J Mol Med 1998; 76(6): B9.no abstract available
Augmentation of host defence against bacterial and fungal infections of mice pretreated with the non-pathogenic Escherichia coli strain Nissle 1917.)
Hockertz, S. - [German] Arzneim-Forsch /Drug Res 1997; 47(I): 793-796.this abstract at pubmed.com
The effect of E. coli strain Nissle 1917 on rat colon motility in vitro.
Voderholzer, W. A. - Gastroenterology 1997; 112(Suppl): A-847.no abstract available
Establishment of E. coli Nissle 1917 and its interaction with Candida albicans in gnotobiotic rats.
Lorenz, A., Schulze, J. - Microecol Ther 1996; 24: 45-51.no abstract available
Properties of Escherichia coli strains of serotype O6.
Blum, G., et al. - Infection 1995; 23(4): 234-236.
this abstract at pubmed.com
Stimulation of intestinal immune cells by E. coli in gnotobiotic piglets.
Mandel, L., et al. - Adv Exp Med Biol 1995; 371A: 463-464.this abstract at pubmed.com
Recolonization therapy with nonadhesive Escherichia coli for treatment of inflammatory bowel disease.
McCann, M. L., et al. - Ann N Y Acad Sci 1994; 730: 243-245. this abstract at pubmed.com
Immunomodulating effect of killed, apathogenic Escherichia coli, strain Nissle 1917, on the macrophage system.
Hockertz, S. - [German] Arzneim -Forsch /Drug Res 1991; 41(II): 1108-1112.this abstract at pubmed.com
The development of an aerobic intestinal microflora in newborn infants.
Sonnenborn, U., et al. - [German] Fortschr Med 1990; 108: 1-7.this abstract at pubmed.com
Green fluorescent protein for detection of the probiotic bacterium Escherichia coli strain Nissle 1917 (EcN) in vivo.
Schultz, M., et al. - J Microbiol Methods 2005; 61(3):389-398.
this abstract at pubmed.com
Schlee, M., et al. -
no abstract available
no abstract available